Alnylam Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2836 www.alnylam.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Alnylam (ALNY) Expands Its RNAi Therapeutics Reach Into Four More Nordic Countries - Jun 22nd, 2026 8:15 am
Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra? - Jun 22nd, 2026 6:26 am
Alnylam Taps Generative AI And Nordic Expansion As Market Lags Targets - Jun 14th, 2026 10:11 am
Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum? - Jun 12th, 2026 7:20 am
Alnylam to Host Tenth "RNAi Roundtable" Webcast Series - Jun 12th, 2026 7:00 am
Junevity Partners with Sunrise BioVentures as Advisors to Accelerate siRNA Therapeutic Development - Jun 10th, 2026 6:02 am
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region - Jun 10th, 2026 5:47 am
Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts - Jun 9th, 2026 11:03 am
Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500 - Jun 8th, 2026 3:06 pm
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer - Jun 8th, 2026 5:00 am
Why Is Sarepta Therapeutics (SRPT) Down 19.9% Since Last Earnings Report? - Jun 5th, 2026 9:30 am
Alnylam Pharmaceuticals (ALNY) Valuation Check As US$2b AI RNAi Collaboration With Inceptive Nucleics Gains Attention - Jun 5th, 2026 5:13 am
Stocks Rebound on Strength in Banks and Managed Healthcare - Jun 4th, 2026 2:32 pm
JPMorgan Says Buy the Dip in These 2 Large-Cap Biotech Stocks - Jun 4th, 2026 11:30 am
Alnylam Bets on AI for Speedy RNAi Drug Discovery and Development - Jun 4th, 2026 9:27 am
Stocks Mixed as Tech Weakness Weighs - Jun 4th, 2026 9:16 am
Weakness in Technology Stocks Pressures Stock Indexes - Jun 4th, 2026 8:10 am
Alnylam, Inceptive ink AI deal potentially worth $2B - Jun 4th, 2026 4:42 am
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics - Jun 3rd, 2026 2:45 pm
Are Options Traders Betting on a Big Move in Alnylam Stock? - May 30th, 2026 12:55 pm